Table of Contents
In 2011, a trader at UBS named Kweku Abiodua Adoboli managed to lose $2.3 billion of the bank’s money. Not over a decade. Not through some elaborate corporate conspiracy. Over a matter of months, through unauthorized trades that he hid with the kind of creativity that, in another context, might have earned him a promotion.
The story is usually told as a morality tale about greed, weak oversight, and the dangers of giving young traders too much rope. But there is a more interesting story underneath. One that involves cortisol, dopamine, the architecture of the human stress response, and the strange fact that the same biological machinery that once helped us outrun predators now helps traders blow up balance sheets.
This is not just a story about fraud. It is a story about chemistry.
The Molecule That Makes You Stupid
Let us start with cortisol, the stress hormone. When you encounter a threat, your adrenal glands flood your bloodstream with it. Your heart rate climbs. Your muscles tighten. Blood moves away from your digestive system and toward your limbs. You become, in the most literal sense, an animal preparing to fight or flee.
This is a spectacular system if the threat is a lion. It is a terrible system if the threat is a spreadsheet showing that your hidden positions are few billions larger than anyone knows.
Here is the problem. Cortisol does not just prepare your body for action. It also impairs your prefrontal cortex, the part of the brain responsible for judgment, long term planning, and the ability to pause before doing something catastrophically stupid. Neuroscientist John Coates, who spent years studying traders on Wall Street before returning to academia, documented this phenomenon extensively. Under chronic stress, traders do not just make worse decisions. They make structurally different kinds of decisions. They become less capable of evaluating risk. They fixate on short term outcomes. They double down.
Adoboli did not wake up one morning and decide to become a rogue trader. He drifted into it. The early unauthorized trades were small. Some of them even made money. But each one raised his baseline stress level, which degraded his capacity to evaluate the next decision clearly, which made the next unauthorized trade more likely. The biology created a feedback loop that the compliance department never had a chance of detecting, because it was happening inside his nervous system.
Dopamine and the Slot Machine on the Trading Floor
If cortisol is the molecule that impairs judgment, dopamine is the one that keeps you coming back for more. And this is where the story gets genuinely counterintuitive.
Dopamine is often described as the “pleasure chemical,” but that is a simplification that borders on being wrong. Dopamine is really about anticipation. It fires not when you receive a reward, but when you expect one. More importantly, it fires most intensely when the reward is uncertain. This is why slot machines are more addictive than vending machines. The vending machine gives you exactly what you paid for. The slot machine might give you nothing, or it might change your life. Your brain finds the second scenario irresistible.
A trading floor is, neurochemically speaking, a room full of slot machines staffed by people in expensive suits.
Every open position is an unresolved bet. Every blinking price on a screen is a potential reward or punishment. The environment is practically engineered to maximize dopamine release, which means it is practically engineered to make people behave compulsively. Adoboli was not operating in a vacuum. He was operating in an environment that, at the molecular level, was pulling him toward exactly the kind of behavior that eventually destroyed him.
This does not excuse what he did. But it does reframe the question. Instead of asking “how could one person do this,” it might be more useful to ask “how does anyone in that environment not do this.” The answer, of course, is that most people have enough counterbalancing factors, including fear, institutional loyalty, the simple desire to keep their job, to resist the pull. But the pull is always there.
The Paradox of Risk Management
Here is where we arrive at the institutional blind spot. Banks spend enormous sums on risk management. UBS, at the time of Adoboli’s trading, had layers of controls, reporting structures, and compliance officers whose entire purpose was to catch exactly this kind of thing. They failed.
The usual explanation is that the systems were not good enough, or that people were not paying attention. Both are true. But there is a deeper issue. Risk management systems are designed to monitor positions, exposures, and financial flows. They are designed to catch abnormal numbers. What they are not designed to catch is abnormal neurochemistry.
A trader whose cortisol levels have been elevated for weeks is, from the bank’s perspective, indistinguishable from a trader who is performing well under pressure. The outward behavior might look the same: long hours, intense focus, confidence. The internal reality could not be more different. One trader is functioning. The other is biologically incapable of rational risk assessment but still has access to the same systems and the same capital.
Think of it this way. Imagine an airline that monitored the mechanical condition of its aircraft down to every bolt and rivet but never checked whether the pilots had slept. You would consider that airline negligent. Yet this is essentially how most trading floors operate. The machines are monitored. The humans, are they really?
When Concealment Becomes Its Own Drug
There is another layer to the biochemistry of rogue trading that rarely gets discussed. The act of concealment itself generates its own neurochemical reward.
Keeping a secret, especially a dangerous one, creates a state of heightened arousal. The brain treats it as a continuous low grade threat, which means continuous cortisol, but also continuous alertness, focus, and a peculiar sense of control. Psychologists who study deception have noted that successful liars often describe a feeling of power. They are managing a reality that no one else can see. They are, in their own minds, the smartest person in the room.
This is intoxicating. And it explains why rogue traders so rarely stop on their own, even when they have the opportunity. Adoboli had moments where his unauthorized positions were actually profitable. He could have unwound them, returned to normal trading, and no one would ever have known. He did not. Because by that point, the concealment was not just a necessity. It was part of the experience.
What This Means for the Rest of Us
You do not need to be a rogue trader to recognize these dynamics in your own life. Anyone who has ever doubled down on a bad decision, not because the evidence supported it but because admitting the mistake felt worse than continuing, has experienced a mild version of the same biochemistry.
The cortisol loop is everywhere. In the entrepreneur who keeps funding a failing startup with personal savings. In the poker player who chases losses. In the investor who refuses to sell a stock that has dropped 60% because selling would make the loss “real.” The biology does not care about the context. It only knows that admitting failure triggers a stress response, and avoiding that stress response feels, in the moment, like the rational choice.
Understanding this does not make you immune to it. But it does give you one useful tool: the ability to recognize when your body is making decisions that your mind should be making. When you notice that your reasons for continuing a losing course of action are getting more creative rather than more convincing, that is your cortisol talking. When you feel a strange thrill from maintaining a position that you know is wrong, that is your dopamine talking.
The rogue trader is not a different species. He is an ordinary person whose ordinary biology was placed in extraordinary circumstances and allowed to run unchecked. The lesson is not that some people are wired for fraud. The lesson is that all of us are wired for self-deception, and the only defense is designing systems and habits that account for that wiring instead of pretending it does not exist.
Kweku Adoboli went to prison. UBS absorbed the loss. The industry commissioned reports and tightened controls. And somewhere, right now, on a trading floor in London or New York or Singapore, another ordinary nervous system is encountering a small, manageable problem and beginning the slow, biochemical process of turning it into an unmanageable one.
The spreadsheet might not catch it. The compliance team might not catch it. The body already knows.
